Fujita Hikaru, Hayakawa Naoko, Kunishima Munetaka
Faculty of Pharmaceutical Sciences, Institute of Medical, Pharmaceutical, and Health Sciences, Kanazawa University , Kakuma-machi, Kanazawa 920-1192, Japan.
J Org Chem. 2015 Nov 6;80(21):11200-5. doi: 10.1021/acs.joc.5b02059. Epub 2015 Oct 20.
We have demonstrated O-benzylating abilities of both 4,6-bis(benzyloxy)-1,3,5-triazin-2(1H)-one (DiBOT) and 6-(benzyloxy)-1,3,5-triazine-2,4(1H,3H)-dione (MonoBOT), which have been previously suggested as reaction intermediates of the acid-catalyzed benzylation of 2,4,6-tris(benzyloxy)-1,3,5-triazine (TriBOT). We studied the effect on the reactivity of acid-catalyzed O-benzylation caused by the isomeric core triazine structures in these compounds by carrying out a kinetic study and estimating relative basicities using model compounds. Since MonoBOT showed superior reactivity, 1,3,5-triazine-2,4(1H,3H)-dione is a promising core structure for acid-catalyzed alkylating reagents.
我们已经证明了4,6-双(苄氧基)-1,3,5-三嗪-2(1H)-酮(DiBOT)和6-(苄氧基)-1,3,5-三嗪-2,4(1H,3H)-二酮(MonoBOT)的O-苄基化能力,它们先前被认为是2,4,6-三(苄氧基)-1,3,5-三嗪(TriBOT)酸催化苄基化反应的中间体。我们通过进行动力学研究并使用模型化合物估计相对碱度,研究了这些化合物中异构核心三嗪结构对酸催化O-苄基化反应活性的影响。由于MonoBOT表现出优异的反应活性,1,3,5-三嗪-2,4(1H,3H)-二酮是酸催化烷基化试剂的一个有前景的核心结构。